|
ZNF81 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.70099498322907E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.88420001612633E-09 |
| Normal-vs-Stage2 |
8.164200E-04 |
| Normal-vs-Stage3 |
1.86669999457933E-08 |
| Normal-vs-Stage4 |
1.26269994460415E-09 |
| Stage1-vs-Stage2 |
5.021800E-01 |
| Stage1-vs-Stage3 |
1.319170E-01 |
| Stage1-vs-Stage4 |
8.263800E-03 |
| Stage2-vs-Stage3 |
1.465250E-01 |
| Stage2-vs-Stage4 |
3.506300E-02 |
| Stage3-vs-Stage4 |
3.218200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20599974451352E-10 |
| Normal-vs-AfricanAmerican |
1.202230E-04 |
| Normal-vs-Asian |
7.90550000018264E-07 |
| Caucasian-vs-AfricanAmerican |
7.810200E-01 |
| Caucasian-vs-Asian |
7.152600E-01 |
| AfricanAmerican-vs-Asian |
5.938000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05590003407485E-09 |
| Normal-vs-Female |
3.96110033662467E-10 |
| Male-vs-Female |
3.343400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.61240000240426E-08 |
| Normal-vs-Age(41-60Yrs) |
2.31109997805845E-09 |
| Normal-vs-Age(61-80Yrs) |
6.82859999656671E-08 |
| Normal-vs-Age(81-100Yrs) |
1.918020E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.288600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.692400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.711000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.720400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.910800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.940200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.695800E-02 |
| Classical-VS-Follicular |
8.700400E-01 |
| Classical-VS-Other |
6.532100E-02 |
| Classical-VS-Normal |
7.90580000020746E-07 |
| Tall-VS-Follicular |
1.059420E-01 |
| Tall-VS-Other |
3.046200E-01 |
| Tall-VS-Normal |
5.17070000149999E-08 |
| Follicular-VS-Other |
1.536810E-01 |
| Follicular-VS-Normal |
1.51663999999885E-05 |
| Other-VS-Normal |
7.606100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12539999541639E-08 |
| Normal-vs-N1 |
2.32560000035242E-07 |
| N0-vs-N1 |
4.606400E-01 |
|
|
